Donate

Read our Annual Report

email

Send this article to a friend by filling out the fields below:

Your name:

Your friend's name:

Your friend's email:

Close Send

Thanks for emailing that article!
Tweet

Message from the Board Chair and President

This has been a remarkable year for Glaucoma Research Foundation. Thanks to your generous support and dedicated efforts, a record $3.5 million was invested in our innovative research and education programs in 2012.

Your contributions allowed for the expansion of the Catalyst for a Cure research consortium and funded eight individual research grants. These pioneering studies are producing significant breakthroughs and speeding the pace of discovery to find a cure for glaucoma.

Catalyst for a Cure: A Renewed Focus

Earlier this year, we recruited a second team of investigators to the Catalyst for a Cure consortium to identify new, specific and sensitive biomarkers in glaucoma. The impact of this research will be valuable for both patients and eye doctors as it has the potential to transform how glaucoma is diagnosed and managed in the future.

Our Commitment to Education and Awareness

Glaucoma Research Foundation remains a principal source of information and support for physicians, patients and their families. This year more than 300,000 issues of our Gleams newsletter were distributed through the mail, by doctors’ offices and by email. Our website, www.glaucoma.org, helped over one million visitors with timely and accurate information. Our website and our educational booklet “Understanding and Living with Glaucoma” continue to be primary resources for patients seeking to learn more about their glaucoma diagnosis, treatment options, and Glaucoma Research Foundation research initiatives. .

Speeding the Development of New Therapies

In February 2012, we launched the Glaucoma 360 New Horizons Forum, an annual meeting dedicated to advancing the development of new glaucoma therapies and diagnostic devices for patients. This unique gathering of medicine, industry, finance, and regulatory leaders is a catalyst to advance novel ideas into clinical practice.

Trusted Financial Stewardship

Since 1978, we have invested more than $40 million to advance essential research and education programs. We receive no government funding and rely on private and corporate philanthropy to nurture and sustain our programs. 86 cents of every dollar donated goes directly to research and education programs.

As we approach our 35th anniversary, we remain committed to our mission to prevent vision loss from glaucoma by investing in innovative research, education, and support with the ultimate goal of finding a cure. Thank you for your generous contributions and ongoing partnership in our endeavors.